176 related articles for article (PubMed ID: 38431503)
1. HDL and SARS CoV-2: emerging theragnostic implications.
Rani A; Stadler JT; Marsche G
Trends Mol Med; 2024 May; 30(5):425-428. PubMed ID: 38431503
[TBL] [Abstract][Full Text] [Related]
2. Good Cholesterol Gone Bad? HDL and COVID-19.
Kluck GEG; Yoo JA; Sakarya EH; Trigatti BL
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638523
[TBL] [Abstract][Full Text] [Related]
3. HDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry.
Wei C; Wan L; Yan Q; Wang X; Zhang J; Yang X; Zhang Y; Fan C; Li D; Deng Y; Sun J; Gong J; Yang X; Wang Y; Wang X; Li J; Yang H; Li H; Zhang Z; Wang R; Du P; Zong Y; Yin F; Zhang W; Wang N; Peng Y; Lin H; Feng J; Qin C; Chen W; Gao Q; Zhang R; Cao Y; Zhong H
Nat Metab; 2020 Dec; 2(12):1391-1400. PubMed ID: 33244168
[TBL] [Abstract][Full Text] [Related]
4. Multifaced Roles of HDL in Sepsis and SARS-CoV-2 Infection: Renal Implications.
Stasi A; Franzin R; Fiorentino M; Squiccimarro E; Castellano G; Gesualdo L
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34205975
[TBL] [Abstract][Full Text] [Related]
5. Innate immunity: the first line of defense against SARS-CoV-2.
Diamond MS; Kanneganti TD
Nat Immunol; 2022 Feb; 23(2):165-176. PubMed ID: 35105981
[TBL] [Abstract][Full Text] [Related]
6. Innate immune evasion by SARS-CoV-2: Comparison with SARS-CoV.
Bouayad A
Rev Med Virol; 2020 Nov; 30(6):1-9. PubMed ID: 32734714
[TBL] [Abstract][Full Text] [Related]
7. Cross-Linking Mass Spectrometry Uncovers Interactions Between High-Density Lipoproteins and the SARS-CoV-2 Spike Glycoprotein.
Burnap SA; Ortega-Prieto AM; Jimenez-Guardeño JM; Ali H; Takov K; Fish M; Shankar-Hari M; Giacca M; Malim MH; Mayr M
Mol Cell Proteomics; 2023 Aug; 22(8):100600. PubMed ID: 37343697
[TBL] [Abstract][Full Text] [Related]
8. The Current Status of Research on High-Density Lipoproteins (HDL): A Paradigm Shift from HDL Quantity to HDL Quality and HDL Functionality.
Cho KH
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409326
[TBL] [Abstract][Full Text] [Related]
9. Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D.
Peng MY; Liu WC; Zheng JQ; Lu CL; Hou YC; Zheng CM; Song JY; Lu KC; Chao YC
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065735
[TBL] [Abstract][Full Text] [Related]
10. The molecular mechanism of SARS-CoV-2 evading host antiviral innate immunity.
Gu W; Gan H; Ma Y; Xu L; Cheng ZJ; Li B; Zhang X; Jiang W; Sun J; Sun B; Hao C
Virol J; 2022 Mar; 19(1):49. PubMed ID: 35305698
[TBL] [Abstract][Full Text] [Related]
11. An Update on Innate Immune Responses during SARS-CoV-2 Infection.
Zhang Y; Chen S; Jin Y; Ji W; Zhang W; Duan G
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696490
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 induced HDL dysfunction may affect the host's response to and recovery from COVID-19.
Al-Kuraishy HM; Hussien NR; Al-Niemi MS; Fahad EH; Al-Buhadily AK; Al-Gareeb AI; Al-Hamash SM; Tsagkaris C; Papadakis M; Alexiou A; Batiha GE
Immun Inflamm Dis; 2023 May; 11(5):e861. PubMed ID: 37249296
[TBL] [Abstract][Full Text] [Related]
13. Human Nasal and Lung Tissues Infected
Alfi O; Yakirevitch A; Wald O; Wandel O; Izhar U; Oiknine-Djian E; Nevo Y; Elgavish S; Dagan E; Madgar O; Feinmesser G; Pikarsky E; Bronstein M; Vorontsov O; Jonas W; Ives J; Walter J; Zakay-Rones Z; Oberbaum M; Panet A; Wolf DG
J Virol; 2021 Jun; 95(14):e0013021. PubMed ID: 33893170
[TBL] [Abstract][Full Text] [Related]
14. Current Understanding of the Innate Control of Toll-like Receptors in Response to SARS-CoV-2 Infection.
Jung HE; Lee HK
Viruses; 2021 Oct; 13(11):. PubMed ID: 34834939
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19.
Gusev E; Sarapultsev A; Solomatina L; Chereshnev V
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163638
[TBL] [Abstract][Full Text] [Related]
16. Kinetic Multi-omic Analysis of Responses to SARS-CoV-2 Infection in a Model of Severe COVID-19.
Cantwell AM; Singh H; Platt M; Yu Y; Lin YH; Ikeno Y; Hubbard G; Xiang Y; Gonzalez-Juarbe N; Dube PH
J Virol; 2021 Sep; 95(20):e0101021. PubMed ID: 34319784
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the RLR signaling pathway by SARS-CoV-2 ORF7b is mediated by MAVS and abrogated by ORF7b-homologous interfering peptide.
Xiao X; Fu Y; You W; Huang C; Zeng F; Gu X; Sun X; Li J; Zhang Q; Du W; Cheng G; Liu Z; Liu L
J Virol; 2024 May; 98(5):e0157323. PubMed ID: 38572974
[TBL] [Abstract][Full Text] [Related]
18. ACE2 and Innate Immunity in the Regulation of SARS-CoV-2-Induced Acute Lung Injury: A Review.
Qu L; Chen C; Yin T; Fang Q; Hong Z; Zhou R; Tang H; Dong H
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768911
[TBL] [Abstract][Full Text] [Related]
19. Innate lymphoid cells (ILC) in SARS-CoV-2 infection.
Kumar A; Cao W; Endrias K; Kuchipudi SV; Mittal SK; Sambhara S
Mol Aspects Med; 2021 Aug; 80():101008. PubMed ID: 34399986
[TBL] [Abstract][Full Text] [Related]
20. Antiviral Activity of Influenza A Virus Defective Interfering Particles against SARS-CoV-2 Replication In Vitro through Stimulation of Innate Immunity.
Rand U; Kupke SY; Shkarlet H; Hein MD; Hirsch T; Marichal-Gallardo P; Cicin-Sain L; Reichl U; Bruder D
Cells; 2021 Jul; 10(7):. PubMed ID: 34359926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
